Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
With a market cap of 22.86B, Incyte(INCY) trades at $112.75. The stock has a price-to-earnings ratio of 14.46.
On 2026-10-09, Incyte(INCY) shares started trading at $112.89, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.81M.
The stock's 52-week range extends from a low of $82.82 to a high of $132.60.
The stock's 52-week range extends from a low of $82.82 to a high of $132.60.
INCY News
Incyte and Mirum Pharmaceuticals reported that the U.S. FDA previously approved Atebrioz (zilurgisertib), an oral ALK2 inhibitor for Fibrodysplasia Ossificans P...
RBC Capital raised the firm’s price target on Incyte (INCY) to $114 from $109 and keeps a Sector Perform rating on the shares as part of a broader research note...
Incyte (INCY) moved back into focus for many investors after U.S. regulators cleared Atebrioz for fibrodysplasia ossificans progressiva, and partners reported e...
Analyst ratings
52%
of 31 ratingsMore INCY News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.